Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GOLDENWELL BIOTECH, INC.

Get SEC filing alerts via email and in your feed for GOLDENWELL BIOTECH, INC.

GWLL

GOLDENWELL BIOTECH, INC.

About GOLDENWELL BIOTECH, INC.

Goldenwell Biotech, Inc. is an early-stage company focused on research, development, and production of nutraceuticals and dietary supplements. It licenses proprietary technology for health products, including peptides and plant extracts, targeting health-conscious consumers. The company operates with minimal assets, relies on external financing, and emphasizes innovation in bioactive health solutions within the wellness market.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from GOLDENWELL BIOTECH, INC.

1
1
GOLDENWELL BIOTECH, INC. Goldenwell Biotech Reports Improved Net Loss and Service Revenue Growth in Q3 2025

Via official filing (AI summary) | 6 months ago | 0 comments

2
1
GOLDENWELL BIOTECH, INC. Goldenwell Biotech Reports Reduced Net Loss in Q2 2025, Plans Fundraising for Future Operations

Via official filing (AI summary) | 9 months ago | 0 comments

3
1
GOLDENWELL BIOTECH, INC. Goldenwell Biotech Reports No Revenue and Increased Losses in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

4
1
GOLDENWELL BIOTECH, INC. Goldenwell Biotech Reports Significant Revenue Decline and Increased Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

5
1
GOLDENWELL BIOTECH, INC. Goldenwell Biotech Reports No Sales and Continued Net Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments